Fig. 1From: The antihyperlipidemic effects of fullerenol nanoparticles via adjusting the gut microbiota in vivoThe physiochemical characterizations of fullerenols. a SEM images of NP aggregates (bar = 100 nm), b XPS data, c MALDI-TOF-MS data without a matrixBack to article page